Nektar Therapeutics
NKTR
NKTR
279 hedge funds and large institutions have $3.79B invested in Nektar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 89 increasing their positions, 95 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
279
Holders Change
-7
Holders Change %
-2.45%
% of All Funds
5.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
61
Increased
89
Reduced
95
Closed
61
Calls
$36.1M
Puts
$42.8M
Net Calls
-$6.65M
Net Calls Change
-$6.54M
Top Buyers
| 1 |
BlackRock
New York
|
+$105M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
+$70M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$39M |
| 4 |
Primecap Management
Pasadena,
California
|
+$20.7M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$65.1M |
| 2 |
State Street
Boston,
Massachusetts
|
-$61.9M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$38.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$16.7M |
